Amneal Pharmaceuticals (AMRX) PT Raised to $5 at RBC Capital

March 1, 2021 6:17 AM EST
Get Alerts AMRX Hot Sheet
Price: $0.09 +12.50%

Rating Summary:
    6 Buy, 4 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 5 | Down: 16 | New: 67
Trade Now! 
Join SI Premium – FREE
RBC Capital analyst Randall Stanicky raised the price target on Amneal Pharmaceuticals (: AMRX) to $5.00 (from $4.00) while maintaining a Sector Perform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change